| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.036 | 0.2 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |